[go: up one dir, main page]

PE20081882A1 - Derivados de piridazinona utiles como inhibidores de glucano sintasa - Google Patents

Derivados de piridazinona utiles como inhibidores de glucano sintasa

Info

Publication number
PE20081882A1
PE20081882A1 PE2008000469A PE2008000469A PE20081882A1 PE 20081882 A1 PE20081882 A1 PE 20081882A1 PE 2008000469 A PE2008000469 A PE 2008000469A PE 2008000469 A PE2008000469 A PE 2008000469A PE 20081882 A1 PE20081882 A1 PE 20081882A1
Authority
PE
Peru
Prior art keywords
alkyl
useful
heteroaryl
aryl
glucan synthase
Prior art date
Application number
PE2008000469A
Other languages
English (en)
Inventor
Robert G Aslanina
Jinhua Cao
Kim David Won-Shik
Rongze Kuang
Gang Zhou
Robert Jason Herr
Andrew John Zych
Pauline C Ting
Heping Wu
Nicolas Zorn
Jinhai Yang
Original Assignee
Schering Corp
Albany Molecular Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp, Albany Molecular Res Inc filed Critical Schering Corp
Publication of PE20081882A1 publication Critical patent/PE20081882A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE ----- ES UN ENLACE DOBLE O SIMPLE; A ES O, S; D Y E SON C, N; R3 ES ALQUILO, ARILO, ARILALQUILO, HETEROARILO, CICLENILO, ENTRE OTROS; Y ESTA AUSENTE O ES NR9, -O-, -S-, ENTRE OTROS; R4 ES ALQUILO, ALQUINILO, ALCOXIALQUILO, ALQUENIL-O-ALQUENILO, ENTRE OTROS; Z ES A, B, ENTRE OTROS; n ES 1-4, p ES 0-2; q ES 1-3, R5 ES -SO2-, C=O, HETEROARILO, ENTRE OTROS; R6 ES H, ALQUILO, ARILO, HETEROARILO, CICLOALQUILO, ARILALCOXILO, ENTRE OTROS; R7 ES H, ALQUILO; R8 ES H, ARILO, ALQUILO, HETEROARILO, ENTRE OTROS; R9 ES H, ALQUILO, ARILO, ARILALQUILO, ENTRE OTROS. REFERIDA TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE GLUCANO SINTASA, UTILES EN EL TRATAMIENTO DE INFECCIONES PRODUCIDAS POR HONGOS
PE2008000469A 2007-03-15 2008-03-12 Derivados de piridazinona utiles como inhibidores de glucano sintasa PE20081882A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91817107P 2007-03-15 2007-03-15

Publications (1)

Publication Number Publication Date
PE20081882A1 true PE20081882A1 (es) 2008-12-27

Family

ID=39525788

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000469A PE20081882A1 (es) 2007-03-15 2008-03-12 Derivados de piridazinona utiles como inhibidores de glucano sintasa

Country Status (18)

Country Link
US (1) US8232274B2 (es)
EP (2) EP2137179B1 (es)
JP (3) JP5147866B2 (es)
KR (1) KR20100049500A (es)
CN (1) CN101730692A (es)
AR (1) AR065721A1 (es)
AU (1) AU2008227100B2 (es)
BR (1) BRPI0809238A2 (es)
CA (1) CA2680583A1 (es)
CL (1) CL2008000725A1 (es)
CO (1) CO6220966A2 (es)
EC (1) ECSP099634A (es)
IL (1) IL200906A0 (es)
MX (1) MX2009009948A (es)
PE (1) PE20081882A1 (es)
RU (1) RU2009137946A (es)
TW (1) TW200902516A (es)
WO (1) WO2008115381A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009009849A (es) * 2007-03-15 2009-09-24 Schering Corp Derivados de piridazinona sustituida con piperazina utiles como inhibidores de glucano sintasa.
AU2008225766B2 (en) 2007-03-15 2012-06-07 Novartis Ag Organic compounds and their uses
EP2197873B1 (en) * 2007-09-20 2014-07-16 Irm Llc Compounds and compositions as modulators of gpr119 activity
CN102099036B (zh) 2008-06-03 2015-05-27 英特芒尼公司 用于治疗炎性疾患和纤维化疾患的化合物和方法
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors
US20120088769A1 (en) * 2010-10-11 2012-04-12 Axikin Pharmaceuticals, Inc. Salts of arylsulfonamide ccr3 antagonists
FI20115234A0 (fi) 2011-03-08 2011-03-08 Biotie Therapies Corp Uusia pyridatsinoni- ja pyridoniyhdisteitä
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
GB201111704D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Novel compounds
JO3115B1 (ar) * 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
US9212147B2 (en) 2011-11-15 2015-12-15 Takeda Pharmaceutical Company Limited Dihydroxy aromatic heterocyclic compound
EP2836482B1 (en) * 2012-04-10 2019-12-25 The Regents of The University of California Compositions and methods for treating cancer
AU2013203000B9 (en) * 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
CN103664795B (zh) * 2012-09-06 2017-10-03 华东理工大学 哒嗪酮类化合物及其用途
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
DE112013004898B4 (de) 2012-10-05 2019-09-05 Koninklijke Philips N.V. Medizinisches Bilddarstellungssystem und Verfahren zur Bereitstellung eines verbesserten Röntgenstrahlbildes
GB201222711D0 (en) 2012-12-17 2013-01-30 Takeda Pharmaceutical Novel compounds
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
EP3039019B1 (en) * 2013-08-26 2020-04-22 Purdue Pharma L.P. Azaspiro[4.5]decane derivatives and use thereof
JP6525437B2 (ja) 2014-04-02 2019-06-05 インターミューン， インコーポレイテッド 抗線維性ピリジノン
JP2017517498A (ja) * 2014-04-24 2017-06-29 ヘキシマ リミテッド 薬剤および治療方法
WO2017155879A1 (en) 2016-03-07 2017-09-14 Agrofresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
RU2019132396A (ru) 2017-03-15 2021-04-15 Лунелла Байотек, Инк. Миторибосцины: терапевтические средства на основе митохондрий, направленные на раковые клетки, бактерии и патогенные дрожжи
EP3606913B1 (en) 2017-04-03 2022-04-27 Syngenta Participations AG Microbiocidal oxadiazole derivatives
AU2018334290A1 (en) 2017-09-18 2020-04-02 Goldfinch Bio, Inc. Pyridazinones and methods of use thereof
CN109912476A (zh) * 2019-03-27 2019-06-21 南通宝凯化工有限公司 一种异丙氨基磺酰氯的生产工艺
CN112513029B (zh) * 2019-06-21 2023-10-24 上海翰森生物医药科技有限公司 含氮芳基磷氧化物类衍生物、其制备方法和应用
WO2021113625A1 (en) * 2019-12-06 2021-06-10 Plexxikon Inc. Compounds and methods for cd73 modulation and indications therefor
WO2021222353A1 (en) 2020-04-30 2021-11-04 Gilead Sciences, Inc. Macrocyclic inhibitors of peptidylarginine deiminases
JPWO2023204124A1 (es) * 2022-04-20 2023-10-26

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS565734B2 (es) * 1973-02-28 1981-02-06
DE3048487A1 (de) * 1980-12-22 1982-07-29 Cassella Ag, 6000 Frankfurt Basisch substituierte pyridazine, ihre herstellung und ihre verwendung
ES540813A0 (es) 1985-02-28 1985-11-16 Abello Quimicos Farma Prod Sa Procedimiento de obtencion de 1,2-diazin-3 (2h)-onas con interes farmaceutico
JPH04235975A (ja) * 1991-01-21 1992-08-25 Nissan Chem Ind Ltd ピリダジノン誘導体および害虫防除剤
GB2256587A (en) 1991-06-11 1992-12-16 American Cyanamid Co Acetazolamide in sustained release form
HU227237B1 (en) * 2001-09-27 2010-12-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Substituted alkylpyridazinone derivatives, process for their preparation, pharmaceutical compositions containing them
TW200306822A (en) * 2002-01-31 2003-12-01 Daiichi Seiyaku Co Imidazo[1, 2-a]pyridine derivative
DE10216144A1 (de) * 2002-04-12 2003-11-06 Bayer Ag Substituierte 2-Phenyl-3(2H)-Pyridazinone
US20050209278A1 (en) * 2002-04-25 2005-09-22 Mcdonald Joseph J Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
UA77526C2 (en) * 2002-06-07 2006-12-15 Sanofi Aventis Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy
WO2005051300A2 (en) * 2003-11-19 2005-06-09 Array Biopharma Inc. Bicyclic inhibitors of mek and methods of use thereof
JP5213229B2 (ja) * 2004-04-23 2013-06-19 エグゼリクシス， インコーポレイテッド キナーゼ調節因子および使用方法
GB0524991D0 (en) * 2005-12-08 2006-01-18 Ge Healthcare Ltd Novel imaging agents for fibrosis
WO2007130383A2 (en) * 2006-04-28 2007-11-15 Northwestern University Compositions and treatments using pyridazine compounds and secretases
MX2009009849A (es) * 2007-03-15 2009-09-24 Schering Corp Derivados de piridazinona sustituida con piperazina utiles como inhibidores de glucano sintasa.

Also Published As

Publication number Publication date
JP2014051529A (ja) 2014-03-20
US8232274B2 (en) 2012-07-31
WO2008115381A1 (en) 2008-09-25
MX2009009948A (es) 2009-09-24
BRPI0809238A2 (pt) 2014-09-09
TW200902516A (en) 2009-01-16
JP5147866B2 (ja) 2013-02-20
CO6220966A2 (es) 2010-11-19
CA2680583A1 (en) 2008-09-25
AR065721A1 (es) 2009-06-24
IL200906A0 (en) 2010-05-17
CN101730692A (zh) 2010-06-09
EP2137179A1 (en) 2009-12-30
KR20100049500A (ko) 2010-05-12
JP2010521461A (ja) 2010-06-24
CL2008000725A1 (es) 2008-11-14
ECSP099634A (es) 2009-10-30
US20090170861A1 (en) 2009-07-02
AU2008227100B2 (en) 2014-01-09
AU2008227100A1 (en) 2008-09-25
RU2009137946A (ru) 2011-04-20
EP2137179B1 (en) 2015-09-02
EP2586778A2 (en) 2013-05-01
EP2586778A3 (en) 2013-07-31
JP2013014622A (ja) 2013-01-24

Similar Documents

Publication Publication Date Title
PE20081882A1 (es) Derivados de piridazinona utiles como inhibidores de glucano sintasa
PE20120693A1 (es) Compuestos heterociclos como moduladores de la piruvato cinasa m2 (pkm2)
PE20140185A1 (es) Derivados de heteroarilpiperidina y piperazina como fungicidas
SMP201100019B (it) Composti organici
JO2910B1 (en) Organic compounds
PE20170247A1 (es) Derivados de pirrolidina-2,5-diona, composiciones farmaceuticas y metodos para usar como inhibidores ido1
PE20191020A1 (es) Compuestos quimicos
CO6321232A2 (es) Compuesto de tropano como inhibidores de hsp90
PE20121695A1 (es) 5-alquinil-pirimidinas
EA200971104A1 (ru) Производные бензимидазола
PE20150684A1 (es) Compuestos triciclicos sustituidos como inhibidores del receptor del factor de crecimiento de fibroblastos (fgfr)
PE20161073A1 (es) Amino-heteroaril-benzamidas como inhibidores de cinasa
MX2010006421A (es) Compuestos organicos.
PE20140171A1 (es) Pirazoles fungicidas y sus mezclas
PE20120691A1 (es) Derivados de n1-sulfonil-5-fluoropirimidinona
MX377581B (es) Compuestos antihelmínticos y composiciones y método de uso de los mismos.
CO6470837A2 (es) Quinazolinas sustituidas como fungicidas
PE20140406A1 (es) Moleculas bifuncionales con actividad de reclutamiento de anticuerpos y actividad inhibitoria inicial contra el virus de la inmunodeficiencia humana
PA8855001A1 (es) Monocarbamas
UY35295A (es) ?Compuestos microbicidas novedosos, métodos para su uso y composiciones?.
EA201101621A1 (ru) Производные бензоксазолона в качестве ингибиторов альдостеронсинтазы
PE20060937A1 (es) Derivados de sulfonilbencimidazol como agonistas del receptor cannabinoide 2 (cb2)
PE20080207A1 (es) DERIVADOS DE 1-N-AMINO-2-IMIDAZOLIDINONAS COMO INHIBIDORES DEL CANAL DE POTASIO Kv1.5
PH12014501181A1 (en) N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
CR11197A (es) Derivados de isotiazol y pirazol como fungicidas

Legal Events

Date Code Title Description
FC Refusal